Stress News and Research

RSS

Immunomedics initiates dosing in milatuzumab-doxorubicin conjugate Phase I/II trial for relapsed multiple myeloma

Immunomedics, Inc., a biopharmaceutical company focused on developing monoclonal antibodies to treat cancer and other serious diseases, today announced the dosing of the first patient in a Phase I/II clinical trial of the doxorubicin conjugate of milatuzumab for the treatment of patients with relapsed multiple myeloma.

16 Jun 2010

Biogen Idec initiates enrollment in Phase II BG-12 combination trial for relapsing-remitting multiple sclerosis

Biogen Idec today announced enrollment of the first patient in a multicenter Phase II clinical trial designed to evaluate its investigational oral therapy BG-12 (dimethyl fumarate) in combination with commonly used first-line treatments in patients with relapsing-remitting multiple sclerosis (RRMS).

15 Jun 2010

BIOTRONIK announces commercial availability of new ProMRI Pacing Systems

BIOTRONIK SE & Co. KG, a leading manufacturer of high-quality implantable cardiac devices and pioneer of wireless remote monitoring technologies, announced today the commercial availability of its new ProMRI Pacing Systems — Evia pacemaker series and Safio pacing leads — providing European patients the first portfolio of bradycardia systems that are compatible with Magnetic Resonance Imaging scans under specific conditions.

15 Jun 2010

Tel Aviv University research suggests link between IVF treatments and autism

The first "test tube baby" was born in 1978. With advances in reproductive science, an estimated one percent of all American babies are now born each year through in vitro fertilization. But IVF and other assisted fertility treatments may be solving one problem by creating another, suggests new evidence from Tel Aviv University.

15 Jun 2010

Female endurance sports athletes are at risk for serious health issues, say physicians

Female endurance sports athletes may be at risk for serious health issues, according to physicians at Loyola University Health System. Excessive exercise and inadequate nutrition can lead to problems such as low energy, menstrual irregularity, fertility issues, stress fractures and osteoporosis.

15 Jun 2010

Innovacell Biotechnologie commences enrollment in urocell Phase IIb study for bladder weakness

"First patient in" is the call from the Innsbruck firm, Innovacell Biotechnologie AG, as the first patient was recruited at the MHAT Plovdiv clinic in Bulgaria for the Phase IIb study of the advanced therapy medicinal product, urocell®. The clinical study will be conducted, beside Bulgaria, in the Czech Republic, Germany, Poland and Romania at more than 50 clinics.

15 Jun 2010

Depression and other stress-related psychiatric disorders in women may have biological basis: Research

There may be a biological reason why depression and other stress-related psychiatric disorders are more common among women compared to men. Studying stress signaling systems in animal brains, neuroscience researchers found that females are more sensitive to low levels of an important stress hormone and less able to adapt to high levels than males.

15 Jun 2010

Researchers discover how bacteria boost the immune system

Scientists have long known that certain types of bacteria boost the immune system. Now, Loyola University Health System researchers have discovered how bacteria perform this essential task.

15 Jun 2010

Increased risk of cardiovascular problems can affect people with mild to moderate SDB: Research

Doctors have long known that snoring is hazardous to health for a number of reasons. In addition to restless nights and increased daytime sleepiness, sleep-disordered breathing has a series of associated health problems, including increased risk of cardiovascular disease. While it is not always clear what the association between SDB and a given health problem is, new research exposes that at least one factor may help to explain the increased risk of cardiovascular problems that affects even people with mild to moderate SDB.

15 Jun 2010

My Insurance Expert to sell, distribute ING Term Life Insurance policies

My Insurance Expert, one of the country's leading online services for the comparison and purchase of affordable health insurance plans, is pleased to announce that it has been appointed to sell and distribute ING Term Life Insurance policies.

14 Jun 2010

Lantheus Medical Imaging reports new Phase 4 data from DEFINITY study

Lantheus Medical Imaging, Inc., a worldwide leader in diagnostic medical imaging, today announced new data from a Phase 4, open-label safety study evaluating the effect of DEFINITY® Vial For (Perflutren Lipid Microsphere) Injectable Suspension, an echocardiography contrast agent, on pulmonary and systemic artery hemodynamics in patients with either normal or increased baseline pulmonary artery pressure.

14 Jun 2010

Dr. Carolle Jean-Murat continues to provide much needed services to the people of Haiti

Dr. Carolle Jean-Murat, a San Diego based OB-Gyn surgeon and intuitive healer is returning July 1st to Haiti, the land of her birth, to continue assisting in the humanitarian effort for that devastated country. She has assisted in coordinating a team of 50 doctors, dentists and other emergency medical professionals to accompany her to provide much needed services to the people of Haiti.

14 Jun 2010

Adolescent boys who attempt suicide more likely to be aggressive toward partners

Young men who attempt suicide before age 18 are much more likely as adults to be aggressive toward their girlfriends or wives, including hitting and injuring their partners, according to a new study.

14 Jun 2010

Preliminary addition of Uroplasty to Russell Microcap Index

Uroplasty, Inc., a medical device company that develops, manufactures and markets innovative proprietary products for the treatment of voiding dysfunctions, today announced it has been included on a list of preliminary additions to the Russell Microcap Index posted by Russell Investments on June 11, 2010 on www.russell.com. These changes are expected to go into effect after the close of trading on Friday, June 25, 2010.

14 Jun 2010

ASH wins six awards and two honorable mentions in international Hermes Awards competition

American Specialty Health Incorporated, a national health and wellness organization, won six awards and two honorable mentions in the international Hermes Awards competition for creative professionals involved in the concept, writing, and design of traditional and emerging media. Hermes Creative Awards recognize outstanding work in the industry while promoting the philanthropic nature of marketing and communication professionals.

14 Jun 2010

Consortium formed to improve community disaster readiness and recovery through research programs

Leading Gulf Coast medical centers, universities and public health institutions from Miami to Houston have united to form a consortium to improve community disaster readiness and recovery through research programs targeting health disparities, disaster preparedness and environmental health.

14 Jun 2010

UJI participates in project OPTIMI for early detection of depression

Treatments for mental illnesses are based on medicines and on therapies. Nevertheless it is not being done much to develop effective systems to prevent the appearance of such illnesses. In January starts the European initiative OPTIMI to contribute to the early detection of depression. The research group Labpsitec of the Department of Basic and Clinical Psychology and Psychobiology at the Universitat Jaume I of Castellón, takes part in the project with the design of evaluation strategies for people in situation of risk.

14 Jun 2010

Blood flow interruption during renal surgery can increase risk of chronic kidney disease

Interrupting the blood flow for more than 20 to 25 minutes during kidney cancer (http://www.mayoclinic.org/kidney-cancer/research.html) surgery leads to a greater risk for patients developing chronic kidney disease, a Mayo Clinic and Cleveland Clinic collaborative research team has found. The study was published today in the journal, European Urology.

14 Jun 2010

Chiasma successfully completes Phase I clinical study of Octreolin

Chiasma, Inc., a privately held biopharma company, announced that it has successfully completed a Phase I clinical study evaluating the safety and pharmacokinetics (PK) of its proprietary product Octreolin, which contains the active ingredient octreotide actetate and is administered orally

14 Jun 2010

TransEnterix selects SYSPRO ERP software

SYSPRO, the leading provider of visionary, pragmatic ERP software, has today announced that TransEnterix, a fast-growing medical device manufacturer based in Durham, North Carolina, has selected SYSPRO ERP software after a lengthy selection process that included a thorough analysis of seven mid-range ERP software providers.

11 Jun 2010

Stress News and Research

Immunomedics initiates dosing in milatuzumab-doxorubicin conjugate Phase I/II trial for relapsed multiple myeloma

Biogen Idec initiates enrollment in Phase II BG-12 combination trial for relapsing-remitting multiple sclerosis

BIOTRONIK announces commercial availability of new ProMRI Pacing Systems

Tel Aviv University research suggests link between IVF treatments and autism

Female endurance sports athletes are at risk for serious health issues, say physicians

Innovacell Biotechnologie commences enrollment in urocell Phase IIb study for bladder weakness

Depression and other stress-related psychiatric disorders in women may have biological basis: Research

Researchers discover how bacteria boost the immune system

Increased risk of cardiovascular problems can affect people with mild to moderate SDB: Research

My Insurance Expert to sell, distribute ING Term Life Insurance policies

Lantheus Medical Imaging reports new Phase 4 data from DEFINITY study

Dr. Carolle Jean-Murat continues to provide much needed services to the people of Haiti

Adolescent boys who attempt suicide more likely to be aggressive toward partners

Preliminary addition of Uroplasty to Russell Microcap Index

ASH wins six awards and two honorable mentions in international Hermes Awards competition

Consortium formed to improve community disaster readiness and recovery through research programs

UJI participates in project OPTIMI for early detection of depression

Blood flow interruption during renal surgery can increase risk of chronic kidney disease

Chiasma successfully completes Phase I clinical study of Octreolin

TransEnterix selects SYSPRO ERP software

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest News